| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |